IP Library Granted Patent US 11,560,354
Granted Patent B2
US 11,560,354 · App. 17/091,222 · Granted Jan 24, 2023

Compositions comprising (R)-2-amino-3-phenylpropyl carbamate and uses thereof

Inventor: Fionn Hurley (Baldoyle, IE)
Assignees: Axsome Malta Ltd.; SK Biopharmaceuticals Co., Ltd.
C07C271/12A61K45/06A61P3/04A61P25/24C07B2200/13C07C269/08
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,560,354
App. No.
17/091,222
Granted
Jan 24, 2023
Kind
B2
Abstract

The present invention relates to a newly identified solvate form of (R)-2-amino-3-phenylpropyl carbamate (APC) hydrochloride, a method of preparing APC hydrochloride, and methods of using the same to treat disorders. The invention further relates to methods of producing APC hydrochloride with increased purity.

Claims (8)

1. A composition comprising (R)-2-amino-3-phenylpropyl carbamate hydrochloride and 2-chloropropane, wherein the composition comprises less than about 5 ppm 2-chloropropane.

2. The composition of claim 1 , wherein the composition comprises less than about 1 ppm 2-chloropropane.

3. The composition of claim 1 , wherein the composition is a dosage form.

4. The composition of claim 3 , wherein the composition is an immediate release oral dosage form.

5. The composition of claim 4 , wherein the composition is a tablet or a capsule.

6. A method of treating narcolepsy, cataplexy, excessive daytime sleepiness, drug addiction, sexual dysfunction, fatigue, fibromyalgia, attention deficit/hyperactivity disorder, restless legs syndrome, depression, bipolar disorder, or obesity in a subject in need thereof, or promoting smoking cessation in a subject in need thereof, comprising administering to the subject the composition of claim 1 .

7. The method of claim 6 , wherein the composition is administered once per day.

8. The method of claim 6 , wherein the composition is administered more than once per day.

Assignments (5)
SECURITY INTEREST Recorded May 9, 2025
From: AXSOME THERAPEUTICS, INC.; AXSOME MALTA LTD.
To: WILMINGTON TRUST, NATIONAL ASSOCIATION
Reel/Frame 071247/0836 →
RELEASE OF SECURITY INTEREST Recorded May 6, 2025
From: U.S. BANK TRUST COMPANY, NATIONAL ASSOCIATION, AS SUCCESSOR IN INTEREST TO U.S. BANK NATIONAL ASSOCIATION
To: JAZZ PHARMACEUTICALS IRELAND LIMITED
Reel/Frame 071034/0467 →
SECURITY INTEREST Recorded Sep 9, 2024
From: AXSOME MALTA LTD
To: HERCULES CAPITAL, INC.
Reel/Frame 068900/0023 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 16, 2022
From: JAZZ PHARMACEUTICALS IRELAND LIMITED
To: AXSOME MALTA LTD.
Reel/Frame 060223/0878 →
SECURITY AGREEMENT Recorded May 5, 2021
From: CAVION, INC.; CELATOR PHARMACEUTICALS, INC.; JAZZ PHARMACEUTICALS IRELAND LIMITED; JAZZ PHARMACEUTICALS, INC.
To: U.S. BANK NATIONAL ASSOCIATION
Reel/Frame 056151/0010 →